Published in J Physiol on June 24, 2003
Role of mitochondrial dysfunction in insulin resistance. Circ Res (2008) 3.45
Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest (2005) 2.98
Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci U S A (2006) 2.71
Energy metabolism in heart failure and remodelling. Cardiovasc Res (2008) 2.37
Energy metabolism in heart failure. J Physiol (2003) 2.10
Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation (2009) 2.01
Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc Res (2011) 1.91
A murine model of isolated cardiac steatosis leads to cardiomyopathy. Hypertension (2011) 1.90
PGC-1 coactivators in cardiac development and disease. Circ Res (2010) 1.86
Mitochondria in heart failure. Cardiovasc Res (2010) 1.75
Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res (2013) 1.72
Divergent mitochondrial biogenesis responses in human cardiomyopathy. Circulation (2013) 1.69
PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol (2008) 1.63
Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res (2008) 1.62
Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic hearts. J Physiol (2008) 1.58
Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res (2010) 1.55
The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol (2008) 1.51
Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol (2012) 1.46
Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation. Proc Natl Acad Sci U S A (2008) 1.45
O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart. Proc Natl Acad Sci U S A (2010) 1.43
Potential therapeutic benefits of strategies directed to mitochondria. Antioxid Redox Signal (2010) 1.40
PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ Res (2011) 1.31
Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol (2012) 1.29
Mitochondrial centrality in heart failure. Heart Fail Rev (2008) 1.28
Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction. Genes Dev (2013) 1.21
Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front Physiol (2011) 1.14
Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. Biochim Biophys Acta (2010) 1.13
Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS One (2011) 1.13
Pregnancy as a cardiac stress model. Cardiovasc Res (2014) 1.11
Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation. Cancer Chemother Pharmacol (2010) 1.10
Is There a Link between Mitochondrial Reserve Respiratory Capacity and Aging? J Aging Res (2012) 1.08
Local energetic regulation of sarcoplasmic and myosin ATPase is differently impaired in rats with heart failure. J Physiol (2008) 1.08
Postnatal development of mouse heart: formation of energetic microdomains. J Physiol (2010) 1.07
Linoleate-rich high-fat diet decreases mortality in hypertensive heart failure rats compared with lard and low-fat diets. Hypertension (2008) 1.06
On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure. J Cardiovasc Magn Reson (2011) 1.05
Mitochondrial dysfunction in heart failure. Heart Fail Rev (2013) 1.02
AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function. Diabetes (2007) 0.97
Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. J Transl Med (2010) 0.96
SRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heart. PLoS One (2012) 0.96
Mitochondrial Homeostasis in Acute Organ Failure. Curr Pathobiol Rep (2013) 0.96
New aspects of impaired mitochondrial function in heart failure. J Bioenerg Biomembr (2009) 0.95
The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation. Am J Physiol Heart Circ Physiol (2011) 0.94
The metabolic syndrome and the heart--a considered opinion. Clin Res Cardiol (2006) 0.92
ω-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial enzymes despite no change in adiponectin. Lipids Health Dis (2010) 0.91
Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor γ coactivator 1α/estrogen related receptor axis. J Mol Cell Cardiol (2011) 0.90
Heart failure: a model of cardiac and skeletal muscle energetic failure. Pflugers Arch (2006) 0.90
Mitochondria and heart failure: new insights into an energetic problem. Minerva Cardioangiol (2010) 0.90
Rescue of Heart Failure by Mitochondrial Recovery. Int Neurourol J (2016) 0.89
Physiological and structural differences in spatially distinct subpopulations of cardiac mitochondria: influence of cardiac pathologies. Am J Physiol Heart Circ Physiol (2014) 0.89
Increased expression of fatty-acid and calcium metabolism genes in failing human heart. PLoS One (2012) 0.88
Cardiomyocyte Ogt is essential for postnatal viability. Am J Physiol Heart Circ Physiol (2013) 0.88
Analysis of skeletal muscle gene expression patterns and the impact of functional capacity in patients with systolic heart failure. J Card Fail (2014) 0.87
Myocardial energetics in left ventricular hypertrophy. Curr Cardiol Rev (2009) 0.87
Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure. Congest Heart Fail (2011) 0.87
Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization. Am J Physiol Heart Circ Physiol (2015) 0.87
Functional electrical stimulation of lower limbs in patients with chronic heart failure. Heart Fail Rev (2010) 0.86
Exercise training, energy metabolism, and heart failure. Appl Physiol Nutr Metab (2009) 0.86
The PPARalpha-PGC-1alpha Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium. PPAR Res (2008) 0.86
AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy. Mol Ther (2012) 0.86
Mitochondria as key targets of cardioprotection in cardiac ischemic disease: role of thyroid hormone triiodothyronine. Int J Mol Sci (2015) 0.86
PGC-1 proteins and heart failure. Trends Cardiovasc Med (2012) 0.85
Redox mechanisms of cardiomyocyte mitochondrial protection. Front Physiol (2015) 0.85
Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats. J Cell Mol Med (2011) 0.85
Regional skeletal muscle remodeling and mitochondrial dysfunction in right ventricular heart failure. Am J Physiol Heart Circ Physiol (2011) 0.84
Mitochondrial haplogroups modify the risk of developing hypertrophic cardiomyopathy in a Danish population. PLoS One (2013) 0.82
Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes. Heart Fail Rev (2016) 0.82
Cardiac mitochondrial proteome dynamics with heavy water reveals stable rate of mitochondrial protein synthesis in heart failure despite decline in mitochondrial oxidative capacity. J Mol Cell Cardiol (2014) 0.81
Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure. Heart Fail Rev (2013) 0.80
Mitochondrial and energetic cardiac phenotype in hypothyroid rat. Relevance to heart failure. Pflugers Arch (2007) 0.80
Renin-angiotensin system inhibitors protect against age-related changes in rat liver mitochondrial DNA content and gene expression. Exp Gerontol (2008) 0.80
Metabolic remodeling in moderate synchronous versus dyssynchronous pacing-induced heart failure: integrated metabolomics and proteomics study. PLoS One (2015) 0.79
A cardiac-specific robotized cellular assay identified families of human ligands as inducers of PGC-1α expression and mitochondrial biogenesis. PLoS One (2012) 0.78
Gene expression changes controlling distinct adaptations in the heart and skeletal muscle of a hibernating mammal. Physiol Genomics (2015) 0.78
Gene expression in skeletal muscle of coronary artery disease patients after concentric and eccentric endurance training. Eur J Appl Physiol (2005) 0.78
Sex-specific cardiac cardiolipin remodelling after doxorubicin treatment. Biol Sex Differ (2015) 0.78
Reduced skeletal muscle oxidative capacity and impaired training adaptations in heart failure. Physiol Rep (2015) 0.78
Regulation of skeletal muscle mitochondrial activity by thyroid hormones: focus on the "old" triiodothyronine and the "emerging" 3,5-diiodothyronine. Front Physiol (2015) 0.78
Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences. Oxid Med Cell Longev (2016) 0.78
Effects of the calcium sensitizer OR-1896, a metabolite of levosimendan, on post-infarct heart failure and cardiac remodelling in diabetic Goto-Kakizaki rats. Br J Pharmacol (2010) 0.77
Impaired mitochondrial biogenesis is a common feature to myocardial hypertrophy and end-stage ischemic heart failure. Cardiovasc Pathol (2015) 0.77
A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice. Dis Model Mech (2015) 0.77
Induction of PGC-1α expression can be detected in blood samples of patients with ST-segment elevation acute myocardial infarction. PLoS One (2011) 0.77
Metabolic enzymes dysregulation in heart failure: the prospective therapy. Heart Fail Rev (2016) 0.76
Diminishing impairments in glucose uptake, mitochondrial content, and ADP-stimulated oxygen flux by mesenchymal stem cell therapy in the infarcted heart. Am J Physiol Cell Physiol (2013) 0.76
Docosahexaenoic acid supplementation alters key properties of cardiac mitochondria and modestly attenuates development of left ventricular dysfunction in pressure overload-induced heart failure. Cardiovasc Drugs Ther (2013) 0.76
Homocysteine induces cardiac hypertrophy by up-regulating ATP7a expression. Int J Clin Exp Pathol (2015) 0.76
Mitochondrial pathways to cardiac recovery: TFAM. Heart Fail Rev (2016) 0.76
Tissue-specific and substrate-specific mitochondrial bioenergetics in feline cardiac and skeletal muscles. J Vet Med Sci (2015) 0.75
The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1α pathway. BMC Complement Altern Med (2016) 0.75
Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate. Mol Med Rep (2015) 0.75
Cardiac nuclear receptors: architects of mitochondrial structure and function. J Clin Invest (2017) 0.75
Idiopathic chronic fatigue in older adults is linked to impaired mitochondrial content and biogenesis signaling in skeletal muscle. Oncotarget (2016) 0.75
Creatine and phosphate pools are maintained at energetically optimal levels in the heart during hypertrophic remodeling and heart failure. Conf Proc IEEE Eng Med Biol Soc (2009) 0.75
Promoting PGC-1α-driven mitochondrial biogenesis is detrimental in pressure-overloaded mouse hearts. Am J Physiol Heart Circ Physiol (2014) 0.75
Regulation of myoglobin in hypertrophied rat cardiomyocytes in experimental pulmonary hypertension. Pflugers Arch (2016) 0.75
Peroxisome proliferator-activated receptor-γ coactivator 1 α1 induces a cardiac excitation-contraction coupling phenotype without metabolic remodelling. J Physiol (2016) 0.75
CYP-epoxygenase metabolites of docosahexaenoic acid protect HL-1 cardiac cells against LPS-induced cytotoxicity Through SIRT1. Cell Death Discov (2015) 0.75
Homocysteine injures vascular endothelial cells by inhibiting mitochondrial activity. Exp Ther Med (2016) 0.75
Effect of a high-protein diet on development of heart failure in response to pressure overload. Appl Physiol Nutr Metab (2013) 0.75
Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell (1999) 19.48
Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature (2002) 14.37
Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet (1998) 7.89
Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest (2000) 7.06
Biogenesis of mitochondria. Annu Rev Cell Biol (1988) 6.96
The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol (2000) 6.29
Mitochondrial DNA maintenance in vertebrates. Annu Rev Biochem (1997) 4.96
Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat Genet (2002) 4.48
Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. Science (1991) 4.26
Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol (2001) 4.17
Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab (2001) 3.45
Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta (2002) 3.34
Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation (1996) 2.87
Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation (2001) 2.76
Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochem Biophys Res Commun (2002) 2.75
Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res (2001) 2.62
Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet (1999) 2.57
Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha ) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci U S A (2003) 2.48
Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol Cell Biochem (1998) 2.44
PGC-1, a versatile coactivator. Trends Endocrinol Metab (2001) 2.31
Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta (1987) 2.23
Addition of a 29 residue carboxyl-terminal tail converts a simple HMG box-containing protein into a transcriptional activator. J Mol Biol (1995) 2.17
Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clin Exp Pharmacol Physiol (2002) 2.14
Mitochondrial DNA instability and peri-implantation lethality associated with targeted disruption of nuclear respiratory factor 1 in mice. Mol Cell Biol (2001) 1.83
Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression. J Am Coll Cardiol (2002) 1.81
Transcriptional effects of chronic Akt activation in the heart. J Biol Chem (2002) 1.65
Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res (1993) 1.60
Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy. Proc Natl Acad Sci U S A (2000) 1.40
Electrical stimulation of neonatal cardiomyocytes results in the sequential activation of nuclear genes governing mitochondrial proliferation and differentiation. Proc Natl Acad Sci U S A (1997) 1.29
Mitochondrial abnormalities in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol (1992) 1.29
Cloning and mRNA tissue distribution of human PPARgamma coactivator-1. Int J Obes Relat Metab Disord (1999) 1.28
Failing energetics in failing hearts. Curr Cardiol Rep (2000) 1.24
Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. Cardiovasc Res (2001) 1.21
Functional coupling of creatine kinases in muscles: species and tissue specificity. Mol Cell Biochem (1998) 1.15
Subcellular creatine kinase alterations. Implications in heart failure. Circ Res (1999) 1.14
RNA content differs in slow and fast muscle fibers: implications for interpretation of changes in muscle gene expression. J Histochem Cytochem (1999) 1.14
Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation (2000) 1.14
Skeletal muscle disorders in heart failure. Acta Physiol Scand (2001) 1.13
Induction of nuclear respiratory factor-1 expression by an acute bout of exercise in rat muscle. Biochim Biophys Acta (1998) 1.06
Metabolic myopathy in heart failure. News Physiol Sci (2002) 0.97
Dual influence of disease and increased load on diaphragm muscle in heart failure. J Mol Cell Cardiol (2001) 0.91
Mitochondrial abnormalities in tumor necrosis factor-alpha-induced heart failure are associated with impaired DNA repair activity. Circulation (2001) 0.90
Changes in myocardial protein expression in pacing-induced canine heart failure. Electrophoresis (1999) 0.89
Does angiotensin-converting enzyme inhibition improve the energetic status of cardiac and skeletal muscles in heart failure induced by aortic stenosis in rats? J Mol Cell Cardiol (2003) 0.82
Oxidative myocytes of heart and skeletal muscle express abundant sarcomeric mitochondrial creatine kinase. Histochem J (1999) 0.79
The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron (2001) 4.97
Energetic crosstalk between organelles: architectural integration of energy production and utilization. Circ Res (2001) 2.77
Polyglutamine-containing proteins in schizophrenia. Mol Psychiatry (1999) 1.77
Detection and characterization of viral genomes and search for tumoral antigens in two hamster cell lines derived from tumors induced by bovine papillomavirus type 1. Int J Cancer (1981) 1.66
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene (2012) 1.49
Muscle creatine kinase-deficient mice. II. Cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function. J Biol Chem (1995) 1.44
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Do modulators of the mitochondrial K(ATP) channel change the function of mitochondria in situ? J Biol Chem (2000) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res (1999) 1.16
Functional coupling of creatine kinases in muscles: species and tissue specificity. Mol Cell Biochem (1998) 1.15
Subcellular creatine kinase alterations. Implications in heart failure. Circ Res (1999) 1.14
Calcineurin Co-regulates contractile and metabolic components of slow muscle phenotype. J Biol Chem (2000) 1.14
Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation (2000) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J Am Coll Cardiol (2001) 1.12
Neurohormonal control of calcium sensitivity of myofilaments in rat single heart cells. Circ Res (1990) 1.12
Myofibrillar creatine kinase and cardiac contraction. Mol Cell Biochem (1995) 1.11
T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci (1999) 1.10
Intestinal vascular malformations. Surgery (1979) 1.08
Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle. J Physiol (2002) 1.08
Neuronal injuries induced by perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: animal model for perinatally acquired encephalopathy. Dev Neurosci (2005) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Stimulus specific changes of energy metabolism in hypertrophied heart. J Mol Cell Cardiol (2009) 1.05
Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop. Biochem J (2001) 1.02
Creatine kinase is the main target of reactive oxygen species in cardiac myofibrils. Circ Res (1996) 1.02
Evaluation of a rapid point-of-care test for the detection of gonococcal infection among female sex workers in Benin. Sex Transm Infect (2006) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Rigor tension during metabolic and ionic rises in resting tension in rat heart. J Mol Cell Cardiol (1981) 0.99
Role of creatine kinase in force development in chemically skinned rat cardiac muscle. J Gen Physiol (1987) 0.98
Reversible MM-creatine kinase binding to cardiac myofibrils. Am J Physiol (1987) 0.97
Ca2+ uptake by cardiac sarcoplasmic reticulum ATPase in situ strongly depends on bound creatine kinase. Pflugers Arch (1996) 0.97
Mitochondrial tissue specificity of substrates utilization in rat cardiac and skeletal muscles. J Cell Physiol (2005) 0.96
Glycolysis supports calcium uptake by the sarcoplasmic reticulum in skinned ventricular fibres of mice deficient in mitochondrial and cytosolic creatine kinase. J Mol Cell Cardiol (2000) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
A memory-based foraging tactic reveals an adaptive mechanism for restricted space use. Ecol Lett (2014) 0.95
Metabolic control and metabolic capacity: two aspects of creatine kinase functioning in the cells. Biochim Biophys Acta (1996) 0.95
Increased expression of MDR1 mRNAs and P-glycoprotein in placentas from HIV-1 infected women. Placenta (2005) 0.93
Phosphorylation-dependent alteration in myofilament ca2+ sensitivity but normal mitochondrial function in septic heart. Am J Respir Crit Care Med (2001) 0.93
Myocardial ischemic contracture. Metabolites affect rigor tension development and stiffness. Circ Res (1994) 0.92
Preliminary characterization and biological reduction of putative biogenic iron oxides (BIOS) from the Tonga-Kermadec Arc, southwest Pacific Ocean. Geobiology (2009) 0.92
Dual influence of disease and increased load on diaphragm muscle in heart failure. J Mol Cell Cardiol (2001) 0.91
Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma. Pharmacogenetics (2001) 0.91
Muscle unloading induces slow to fast transitions in myofibrillar but not mitochondrial properties. Relevance to skeletal muscle abnormalities in heart failure. J Mol Cell Cardiol (1998) 0.91
Partial small bowel obstruction secondary to ileal diverticulitis. Radiology (1977) 0.90
Heart failure: a model of cardiac and skeletal muscle energetic failure. Pflugers Arch (2006) 0.90
Developmental changes in regulation of mitochondrial respiration by ADP and creatine in rat heart in vivo. Mol Cell Biochem (2000) 0.90
Creatine kinase in regulation of heart function and metabolism. I. Further evidence for compartmentation of adenine nucleotides in cardiac myofibrillar and sarcolemmal coupled ATPase-creatine kinase systems. Biochim Biophys Acta (1984) 0.90
Amusia due to right temporoparietal infarct. Arch Neurol (1982) 0.90
Structural and functional adaptations of striated muscles to CK deficiency. Mol Cell Biochem (2004) 0.90
On the regulation of cellular energetics in health and disease. Mol Cell Biochem (1997) 0.89
Association of total dose intensity of chemotherapy in primary central nervous system lymphoma (human non-acquired immunodeficiency syndrome) and survival. Neurosurgery (2001) 0.89
Recovery of contractile and metabolic phenotypes in regenerating slow muscle after notexin-induced or crush injury. J Muscle Res Cell Motil (2003) 0.89
The dependence of twitch relaxation on sodium ions and on internal Ca2+ stores in voltage clamped frog atrial fibres. Pflugers Arch (1979) 0.88
Compartmentation of creatine kinases during perinatal development of mammalian heart. Mol Cell Biochem (1995) 0.88
Dependence upon high-energy phosphates of the effects of inorganic phosphate on contractile properties in chemically skinned rat cardiac fibres. Pflugers Arch (1988) 0.87
Effect of cyclosporin A and its vehicle on cardiac and skeletal muscle mitochondria: relationship to efficacy of the respiratory chain. Br J Pharmacol (2001) 0.87
Differential effects of thyroid hormones on energy metabolism of rat slow- and fast-twitch muscles. J Cell Physiol (2005) 0.87
Functional development of the creatine kinase system in perinatal rabbit heart. Circ Res (1991) 0.86
Altered skeletal muscle mitochondrial biogenesis but improved endurance capacity in trained OPA1-deficient mice. J Physiol (2013) 0.86
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86
Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats? J Appl Physiol (1985) (2003) 0.86
Compartmentation of creatine kinase isoenzymes in myometrium of gravid guinea-pig. J Physiol (1993) 0.86
N-acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients. Br J Clin Pharmacol (1994) 0.85
Functional tissue and developmental specificities of myofibrils and mitochondria in cardiac muscle. Can J Physiol Pharmacol (1996) 0.85
Dexamethasone and triamcinolone acetonide accumulation in mouse fibroblasts is differently modulated by the immunosuppressants cyclosporin A, FK506, rapamycin and their analogues, as well as by other P-glycoprotein ligands. J Steroid Biochem Mol Biol (1998) 0.85
Search for gluinos in events with two same-sign leptons, jets, and missing transverse momentum with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.85
Creatine kinase and mechanical and mitochondrial functions in hereditary and diabetic cardiomyopathies. Can J Physiol Pharmacol (1991) 0.85